Colorado legislators back psychedelic drug research
Lawmakers, Trump call for efforts to research ibogaine's potential for treating mental health, substance abuse
social aspects of psychoactive drugs
Reclassification of marijuana opens doors for much-needed medical research into the benefits and risks of the drug
(BINGHAMTON, NY) When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive Schedule I classification.
The Justice Department
US judge orders Purdue Pharma to pay billions ahead of bankruptcy
A US federal judge on Tuesday sentenced OxyContin-maker Purdue Pharma to pay billions of dollars over its role in the opioid crisis, ahead of upcoming bankruptcy proceedings and its dissolution.
The criminal sentencing caps off years of legal battles and paves the way for Purdue and its former owners,
US opioid crisis victims testify at emotional Purdue Pharma hearing
Dozens of victims of the US opioid crisis expressed their grief and anger as they testified on Tuesday against Purdue Pharma, the maker of the pain pill OxyContin which was ordered to pay billions by a judge ahead of its dissolution.
Between 1999 and 2023, around 806,000 people died
US eases access to marijuana for medical use
The US government on Thursday made it easier for Americans to use cannabis for medical reasons by reclassifying the drug and enabling more research into its safety and efficacy.
Marijuana is now described as having moderate to low addiction potential, "expanding patients' access to treatments and empowering doctors
Trump moves medical marijuana to Schedule III in historic shift
(The Center Square) – The Trump administration on Thursday moved medical marijuana from one of the most restricted drug classifications to a less regulated category, a historic shift that delivers a tax break to cannabis businesses but stops short of federal legalization.
Acting Attorney General Todd Blanche issued an order immediately
National Prescription Drug Take Back Day aims to reduce risks
Missoula, Mont. — National Prescription Drug Take Back Day is set for this Saturday, giving people in nationwide a chance to turn in unused or unwanted medications and lower the risk of misuse at home.
Stephen Ferguson, founder and executive director of Crossroads Recovery in Missoula, said keeping old prescriptions can